Literature DB >> 11123386

Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician.

M R Taylor1.   

Abstract

The remarkable advances in the area of genetic testing are transforming the way clinical medicine is practised. In the case of the inherited breast-ovarian cancer syndrome the ability to engage in genetic testing of BRCA genes has raised novel issues over caring for patients who are at increased risk for these malignancies. The primary care physician is likely to play a pivotal role in identifying such persons. As only 10-15% of all breast cancers are caused by directly heritable mutations, cultivating the ability to identify those who may be at increased risk is an important skill for the primary care physician. Once it is established that an individual is at risk of BRCA mutation, the physician must understand the potential benefits and drawbacks of the various genetic BRCA tests. Taking such factors into account leads to the development of an appropriate plan for evaluation. Careful attention must also be paid to social and psychological issues that may affect patients and their families.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123386      PMCID: PMC1741878          DOI: 10.1136/pmj.77.903.11

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  Putting the risk of breast cancer in perspective.

Authors:  K A Phillips; G Glendon; J A Knight
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 2.  Hereditary ovarian cancer: molecular genetics and clinical implications.

Authors:  J Boyd; S C Rubin
Journal:  Gynecol Oncol       Date:  1997-02       Impact factor: 5.482

Review 3.  The new genetics. Psychological responses to genetic testing.

Authors:  T M Marteau; R T Croyle
Journal:  BMJ       Date:  1998-02-28

4.  Genetic testing for cancer risk: how to reconcile the conflicts.

Authors:  E Kodish; G L Wiesner; M Mehlman; T Murray
Journal:  JAMA       Date:  1998-01-21       Impact factor: 56.272

Review 5.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Authors:  W Burke; M Daly; J Garber; J Botkin; M J Kahn; P Lynch; A McTiernan; K Offit; J Perlman; G Petersen; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-26       Impact factor: 56.272

6.  Inherited breast and ovarian cancer. What are the risks? What are the choices?

Authors:  M C King; S Rowell; S M Love
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

7.  BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.

Authors:  K E Malone; J R Daling; J D Thompson; C A O'Brien; L V Francisco; E A Ostrander
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

8.  Contribution of BRCA1 mutations to ovarian cancer.

Authors:  J F Stratton; S A Gayther; P Russell; J Dearden; M Gore; P Blake; D Easton; B A Ponder
Journal:  N Engl J Med       Date:  1997-04-17       Impact factor: 91.245

Review 9.  Genetics of breast cancer.

Authors:  M H Greene
Journal:  Mayo Clin Proc       Date:  1997-01       Impact factor: 7.616

10.  BRCA1 mutations in a population-based sample of young women with breast cancer.

Authors:  A A Langston; K E Malone; J D Thompson; J R Daling; E A Ostrander
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

View more
  2 in total

1.  Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes.

Authors:  Stella Lai; Clare Brookes; Debra O Prosser; Chuan-Ching Lan; Elaine Doherty; Donald R Love
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

Review 2.  Cats, Cancer and Comparative Oncology.

Authors:  Claire M Cannon
Journal:  Vet Sci       Date:  2015-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.